Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (Nasdaq: WBA) announced a commitment of US$350,000 to the American India Foundation to address COVID-19 needs in India. This includes a direct donation of $100,000, matching employee contributions, and in-kind donations of pulse oximeters valued at $50,000. WBA has previously administered over 15 million COVID-19 vaccines and provided access to testing in over 6,000 locations.
Walgreens has launched a Same Day Delivery service, allowing customers to receive retail products within two hours nationwide. Over 24,000 items are available for this service, which does not have a minimum order requirement. Customers can utilize the Walgreens app or website for contactless delivery. The service integrates with the myWalgreens rewards program, enabling users to earn and redeem Walgreens Cash rewards and promotions. This initiative continues Walgreens' commitment to enhancing customer experience following the myWalgreens launch in November 2020.
Walgreens is launching mobile COVID-19 vaccination clinics in Chicago, building on its success with over 700 clinics nationwide. These mobile units aim to serve underserved communities facing access barriers. Individuals can walk up for vaccinations provided by Walgreens pharmacy team members. To date, Walgreens has administered over 15 million vaccines and plans to expand this initiative. Additionally, same-day vaccine appointments will be available, along with partnerships with over 100 employers to enhance access across the country.
Walgreens is launching mobile clinics in Chicago and other locations to provide COVID-19 vaccinations to underserved communities. Following the success of over 700 vaccination clinics, the initiative aims to overcome access barriers. To date, Walgreens has administered more than 15 million vaccines and will offer same-day appointments starting May 5. The company partners with over 100 employers to enhance vaccination efforts and ensure availability of Pfizer, Moderna, and Johnson & Johnson vaccines. Walgreens continues to play a vital role in community health accessibility.
Walgreens Boots Alliance (Nasdaq: WBA) has launched a cash tender offer for up to $3.3 billion of certain senior notes. The offer includes key notes with varying acceptance priority levels. Notably, the 4.100% Notes due 2050 and the 3.100% Notes due 2022 have set tender caps of $200 million and $500 million, respectively. Holders of notes who tender before the April 22, 2021 deadline will receive a total consideration based on reference yields plus a premium. The settlement date for early tenders is expected on April 26, 2021. The offer will expire on May 7, 2021.
Walgreens Boots Alliance (WBA) has announced the results of its amended cash tender offer, increasing the Maximum Tender Amount from $2.75 billion to $3.3 billion. Approximately $3.7 billion of senior notes were validly tendered by the early tender deadline of April 22, 2021. The tender offer includes several series of notes, with priority levels for acceptance. The total consideration for accepted notes will be disclosed following the price determination date of April 23, 2021. The settlement date for early tendered notes is expected by April 26, 2021.
Walgreens Boots Alliance (Nasdaq: WBA) has declared a quarterly dividend of 46.75 cents per share, consistent with the prior quarter and up 2.2% from the previous year. This dividend will be payable on June 11, 2021, to stockholders on record as of May 21, 2021. Notably, WBA has maintained dividend payments for 354 consecutive quarters and has increased dividends for 45 consecutive years, showcasing its commitment to returning value to shareholders.
Walgreens has partnered with Abbott to offer the BinaxNOW™ Rapid Antigen Self Test for COVID-19 in stores and online for $23.99. This agreement aims to improve access to COVID-19 testing nationwide as vaccines become more available. Walgreens will enhance its testing capacity with 6,000 drive-thru sites, including rapid testing options. The self-test, approved by the FDA for home use, allows users to check results in just 15 minutes and can be used by children as young as two. This initiative is part of Walgreens' commitment to public health amid the ongoing pandemic.
On April 12, 2021, PayPal (PYPL), Uber (UBER), and Walgreens (WBA) launched the Vaccine Access Fund, aimed at helping underserved communities access COVID-19 vaccinations. The coalition is contributing $11 million to cover free rides to vaccination sites. Customers can also donate directly through the Uber app. The initiative addresses transportation barriers, especially in communities hit hardest by the pandemic. Funds will be managed by the Local Initiatives Support Corporation (LISC) to enhance health equity.
Walgreens is actively administering COVID-19 vaccines across 49 states, D.C., and Puerto Rico, with over 60,000 immunizers at 7,000 locations. The company has delivered more than 11 million vaccinations, focusing on underserved communities through numerous off-site clinics. As of now, supply is limited and appointments are required, with eligibility varying by state. Walgreens is collaborating with various partners to enhance access, particularly in areas hit hardest by the pandemic. More information is available on their website.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
